Company: PTPI
Filing Date: 2025-02-10
Form Type: S-1/A
Source: 0001410578-25-000108
Chunk: 266

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-10
Form: S-1/A
Chunk 266
---
 of the Event of Default, the Company accrued an additional $ 50,000of interest expense.

F-44

Future minimum principal payments of the Note are as follows:

| ​                                       | ​ | ​ |          ​ |
|:----------------------------------------|:--|:--|-----------:|
| 2024 (remaining 3 months)               |   | $ |    391,271 |
| 2025                                    | ​ | ​ |  2,720,940 |
| 2026                                    | ​ | ​ |  3,264,351 |
| 2027                                    | ​ | ​ |    872,073 |
| Total                                   | ​ | $ |  7,248,635 |
| Less: current portion                   | ​ | ​ | -2,326,050 |
| Promissory note, net of current portion | ​ | $ |  4,922,585 |

9) Stockholders’ Equity On December 21, 2023, the Company approved and accrued for the issuance of $ 200,000of common stock, payable in twoequal installments, with the first installment to be paid upon approval by the Board and the second installment six months after the first installment, to CorProminence, LLC (“CoreIR”) for services rendered pursuant to a Marketing and Consulting Agreement. The first installment of 70,922shares was issued on February 29, 2024. The second installment of 245,158shares was issued on June 21, 2024. On January 5, 2024, the Company executed an advisory agreement (“Maxim Agreement”) with Maxim Group LLC (“Maxim”) that included the issuance of $ 10,000of the Company’s restricted common stock per month and issued every six months starting upon the execution of the agreement. The first installment of 6,906shares was issued on January 5, 2024. The second installment of 136,986shares was issued on August 13, 2024. On August 20, 2024, the Company delivered written notice of termination of the Maxim Agreement, effective September 30, 2024. Accordingly, the Maxim Agreement terminated in accordance with its terms on September 30, 2024.

10) Stock Options

The following is a summary of stock options for the nine months ended September 30, 2024:

| ​                                         
 ​                                         
 ​                                         
 ​                                         
 ​                                         | ​ 
 ​